Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta

NCT02650973 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CHS-1701
DRUG: Pegfilgrastim

Sponsor

Coherus Oncology, Inc.